Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
M&A activity
confidence 95%
filed 2026-09-29
Item 8.01
The filing discloses the public filing of a Form S-4 registration statement for a proposed business combination between Silicon Valley Acquisition Corp. (SVAQ) and EigenQ, Inc., previously announced on June 17, 2026. The disclosure explicitly states that "SVAQ is expected to domesticate to become a Delaware corporation and, following completion of the Business Combination, be renamed as EigenQ Holdings, Inc." with EigenQ surviving as a wholly owned subsidiary. This represents a material merger/change of control transaction subject to shareholder approval, with expected closing in Q4 2026.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-09-29
EX-99.1
This exhibit discloses unaudited pro forma financial information for a reverse merger between SAIHEAT Limited (the legal acquirer) and Canopy Wave Inc. (the accounting acquirer), with Canopy Wave surviving as a wholly-owned subsidiary. The Merger Agreement is dated August 10, 2026, with merger consideration of 3,306,269 SAIHEAT ordinary shares valued at US$18.15 per share, plus a concurrent PIPE investment of 247,970 shares for US$4.5 million. This is a material acquisition/change of control transaction that would significantly affect investor assessment of the combined entity's financial position and operations.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-29
EX-99.1
TC Energy announced that Coastal GasLink Phase 2 will proceed following LNG Canada's positive Final Investment Decision on its expansion. This is a material operational and strategic milestone—the company is proceeding with a major pipeline capacity expansion project (nearly doubling existing capacity) that will generate significant capital investment, employment, and long-term revenue. While the project involves infrastructure development and capital deployment, it does not fit the discrete event categories of M&A, debt issuance, or workforce reduction; it is best classified as a material operational/strategic business milestone.
View raw filing on EDGAR →
8-K
Workforce Reduction
confidence 92%
filed 2026-09-29
Item 2.05
Westlake announced the closure of its Cologne PVC plant in Germany, resulting in a workforce reduction of approximately 120 employees and total pre-tax charges of approximately $205 million ($100 million cash, $105 million non-cash), including severance costs (~$20 million), decommissioning costs (~$80 million), and asset write-offs (~$45 million). The facility will cease operations in Q1 2027, with approximately $110 million in charges expected in 2026 and the remainder in 2027.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-29
EX-99.1
This press release announces the launch of a new Zcash (ZEC) exchange-traded product (ETP) by Valour, a subsidiary of DeFi Technologies. The disclosure describes a product innovation and market expansion—the company is adding a new digital asset ETP to its platform of over 100 products, expanding regulated access to ZEC through traditional brokerage infrastructure. This is a material operational/strategic event reflecting the company's core business strategy of bridging traditional capital markets and decentralized finance, though it does not fit the specific categories of M&A, earnings, executive changes, or other named event types.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-29
CSN's subsidiary announced a temporary reduction in lower-grade iron ore production at its Pires Complex due to challenging market conditions and higher freight costs, coupled with downward revisions to 2026 production guidance (45.0–47.0 Mt to 39.0–41.0 Mt) and upward revisions to C1 cash costs (US$22.0–23.5/ton to US$25.0–26.0/ton). This is a material operational and strategic decision affecting production volumes and cost structure, but does not fit the specific categories of workforce_reduction, ma_activity, or other named types—it is a production adjustment with market-driven rationale.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 92%
filed 2026-09-29
Vale S.A. announces a semi-annual premium payment on participating debentures of R$ 512.2 million (R$ 1.712064114 per debenture) to be paid on September 30, 2026. This is a distribution to debenture holders calculated as a percentage of net revenues from iron ore and copper sales, constituting a material return of value to security holders that would affect investor assessment of cash deployment and shareholder returns.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 92%
filed 2026-09-29
Azul executed a definitive loan agreement with BNDES under the FNAC financing program providing access to up to R$2.66 billion in long-term financing, with the first tranche of approximately R$1.3 billion drawn immediately. This constitutes creation of a new direct financial obligation through debt issuance, material to investors assessing the company's capital structure and liquidity position.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-29
Item 2.03
The filing discloses the issuance of consolidated obligation bonds by the Federal Home Loan Bank of San Francisco under Item 2.03. Schedule A reports a $25 million bond with a trade date of 9/23/2026, settlement date of 10/05/2026, and maturity date of 7/03/2030, bearing a 5.150% coupon. This represents a direct financial obligation created through debt issuance, which is the core purpose of Item 2.03 disclosures.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-29
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Des Moines. Schedule A lists multiple debt securities with trade dates in September 2026, including fixed-rate bonds, variable-rate floaters, and callable bonds totaling over $2 billion in principal. This is a classic debt issuance disclosure under Item 2.03, material to the Bank's capital structure and funding activities.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-29
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Topeka. Schedule A details multiple debt securities issued on trade dates in September 2026, including fixed-rate bonds totaling $25 million and variable-rate floaters totaling $1.7 billion, representing new debt obligations. This is a classic debt_issuance event under Item 2.03, disclosing the creation of new direct financial obligations in the capital markets.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-29
Item 5.02
The Board appointed Richard Menziuso as Vice President, Global Controller and Principal Accounting Officer effective September 29, 2026. This is a clear executive appointment to a named officer role with significant accounting and financial reporting responsibilities. The disclosure includes detailed background on his 28 years of finance and accounting experience and prior roles at major companies, consistent with standard executive appointment disclosures under Item 5.02.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-29
Item 2.03
The filing discloses the issuance of Consolidated Bonds and Consolidated Discount Notes by the Federal Home Loan Bank of Cincinnati, creating direct financial obligations. Schedule A lists multiple bond issuances with trade dates of 9/24/2026 and 9/25/2026, with principal amounts ranging from $1 billion to $13 million across various maturities and coupon rates. This is a routine Item 2.03 disclosure of debt creation, which is material to the registrant's capital structure and financial obligations.
View raw filing on EDGAR →
8-K
Workforce Reduction
confidence 93%
filed 2026-09-29
Item 2.05
Workday announced a workforce reduction of approximately 2.5% of its current workforce, primarily within the Product and Technology team, along with leased office space reductions. The company estimates total charges of $65–80 million, including $40–55 million in severance and employee benefits, $10 million in stock-based compensation charges, and $15 million in non-cash impairment charges for leased office space.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-29
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Pittsburgh. Schedule A details multiple debt issuances with trade dates of 9/23-9/25/2026, including fixed-rate bonds ranging from 3-20 year maturities and variable-rate floaters totaling over $1.3 billion in principal. This is a classic debt_issuance event under Item 2.03, and the registrant explicitly notes that "consolidated obligations issuance is material to the FHLBank."
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-29
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Chicago. Schedule A details multiple debt securities issued on trade dates in September 2026, with principal amounts totaling approximately $115 million across five distinct bond issuances with varying maturity dates (2029–2056) and coupon rates (5.2%–7.0%). This is a classic debt_issuance event under Item 2.03, and the aggregate principal amount and multi-tranche structure make it material to investors assessing the Bank's capital structure and financial obligations.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-29
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Boston. Schedule A details six specific debt issuances with trade dates in September 2026, ranging from $10 million to $300 million in principal amount, with maturities from 2027 to 2031. This represents the creation of new direct financial obligations as contemplated by Item 2.03, and the aggregate principal amount ($870 million) is material to the registrant.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-29
Item 2.03
The filing discloses the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Atlanta on trade dates in September 2026, with principal amounts totaling approximately $4.985 billion across multiple securities with varying maturities and rate structures. Schedule A details specific debt securities issued, including their CUSIPs, settlement dates, maturity dates, coupon rates, and principal amounts, which is the hallmark of a debt_issuance disclosure under Item 2.03.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-09-29
Item 5.02
Chad A. Brandt was appointed Executive Vice President - Chief Financial Officer effective September 1, 2026, representing a promotion from Senior Vice President - Chief Financial Officer, with an annual base salary of $480,000 and participation in incentive plans.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-09-29
Item 8.01
FHLBank Indianapolis disclosed a material reorganization of executive leadership, including promotions of six executives (Chad A. Brandt, Kristina L. Cunningham, Jonathan W. Griffin, John D. Bingham, Stephanie L. Lesnet, Jeffrey D. Mills) to key governance roles and the appointment of Gurdeepak Singh as Chief Technology Officer, reflecting strategic realignment of the Bank's leadership structure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-29
Item 2.03
The filing discloses the Federal Home Loan Bank of Indianapolis becoming the primary obligor on consolidated obligation bonds with aggregate par value of approximately $900 million across multiple tranches with settlement dates in September and October 2026. This constitutes creation of direct financial obligations through debt issuance, the core event type for Item 2.03 disclosures of this nature.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-29
Item 2.03
The filing discloses the creation of multiple consolidated obligation bonds committed to be issued by the Federal Home Loan Bank of Dallas, totaling approximately $4.451 billion in par amount across 11 separate bond issuances with various maturity dates, coupon rates, and structures. This represents the creation of direct financial obligations under Item 2.03, which is the core purpose of this 8-K filing. The Bank explicitly notes it "obtains most of its funds from the sale of debt securities, known as consolidated obligations," making these issuances material to the registrant's capital structure and funding activities.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-29
Item 5.02
The filing discloses the Board's election of Richard J. Daly as a director effective October 14, 2026. The principal action is a person taking a role—Daly's appointment to the Board as a Class I director. While the disclosure also mentions compensatory arrangements (57,000 stock options), the core event is the appointment itself. This is material because board composition changes affect governance and investor assessment of the company's leadership and strategic direction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-09-29
Item 2.01
Fox Factory completed the sale of its wholly owned subsidiary Wheelhouse Holdings Inc. (parent of Marucci Sports, LLC) to Squared Up Holdings, LLC on September 25, 2026, for $225 million enterprise value ($200 million cash plus $25 million convertible note), resulting in a $120.1 million loss on disposal. The disposition materially affects the registrant's financial position, with pro forma statements showing removal of $413 million in assets and $79-186 million in revenues.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-09-29
Item 2.02
Uranium Energy Corp announced fiscal year 2026 financial results for the period ended July 31, 2026, disclosing revenue of $37.3 million, gross profit of $16.9 million, production volumes of 229,294 pounds, a realized sales price of $93.13 per pound, and balance sheet highlights including $753 million in liquid assets and no debt.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-09-29
Item 7.01
Moleculin announced completion of enrollment in Part A of its pivotal Phase 2/3 MIRACLE trial for Annamycin in R/R AML, with 89 subjects enrolled and a planned Q1 2027 data readout. This is a material clinical development milestone for a Phase 3 stage biopharmaceutical company whose lead program depends on successful trial execution. While not fitting the specific categories of earnings, M&A, impairment, or litigation, this represents a significant operational and strategic milestone in the company's drug development pathway that would affect a reasonable investor's assessment of near-term catalysts and program progress.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-09-29
Item 8.01
Capstone retired approximately 85% of its convertible note principal ($5.82M of $6.82M) through a combination of convertible note conversions (2.4 million shares) and an equity line of credit with Tumim Stone Capital (3.4 million shares), resulting in a material 28% increase in outstanding shares and a strengthened capital structure with elimination of convertible debt overhang.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-29
Item 8.01
Apyx Medical announced publication of new clinical study data in a peer-reviewed journal demonstrating that Renuvion helium plasma radiofrequency technology produces measurable biological improvements in skin quality (increased elastin, reduced inflammation, favorable dermal remodeling). This is a material operational/product milestone—positive clinical evidence supporting the company's core product efficacy—but does not fit the specific event types (earnings, M&A, impairment, litigation, etc.). The disclosure is clearly operational in nature and material to investor assessment of the company's product value proposition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-09-29
Item 5.07
This is a clear disclosure of shareholder vote results from Byrna Technologies' 2026 Annual Meeting of Stockholders held on September 25, 2026. The filing reports voting outcomes for three proposals: election of eight directors, ratification of EisnerAmper LLP as independent auditors, and non-binding approval of executive compensation. The detailed vote tallies (votes for, against, abstained, and broker non-votes) for each proposal are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-29
Item 8.01
The Company increased the maximum aggregate offering price under an at-the-market (ATM) sales agreement with Benchmark and StoneX by $966,000 to a total of $5,465,000. This is a dilutive equity issuance under an ATM offering facility, which is a material capital-raising activity that increases share dilution and is commonly disclosed as Item 8.01 for ATM program updates.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-09-29
Item 5.01
David E. Lazar sold his Series AA and Series AAA Preferred Shares (convertible into 241.9 million common shares) to multiple purchasers on September 25, 2026, resulting in a change of control and material restructuring of the company's capitalization and ownership structure. Lazar's ownership was reduced from potential control to 3.1%, with no single purchaser exceeding 9.99% ownership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-09-29
Item 5.02
William H. Crampton was appointed as a director and member of the Audit and Compensation Committees on September 25, 2026, and received an equity grant of 301,205 restricted shares. The appointment represents a material change in board composition and governance structure.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-09-29
Item 8.01
The Company announced a cash distribution of approximately $0.9936 per contingent value right (CVR) to be paid on or about October 2, 2026, triggered by Proceeds Events under the CVR Agreement (asset sale and securities purchase agreement closing).
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-29
Item 8.01
Cartesian Therapeutics announced positive Phase 2 retreatment data for Descartes-08 in myasthenia gravis patients, demonstrating sustained clinical efficacy with a mean MG-ADL reduction of 6.6 points at Month 12 post-retreatment and a favorable safety profile with no new safety signals. This clinical milestone is material to investor assessment of the company's lead asset development trajectory as it approaches Phase 3 AURORA topline results expected in 1Q27.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-09-29
Item 2.03
On September 28, 2026, Onar Holding Corp entered into Securities Purchase Agreements creating approximately $15 million in new convertible promissory notes (8% interest, 18-month maturity) and $5 million in senior secured convertible notes (12% interest, September 2027 maturity), with $3.9 million of each issued at closing. Additionally, the Company exchanged approximately $6.5 million of existing indebtedness into new Exchange Notes, with all obligations secured by substantially all Company assets and convertible into preferred equity upon Nasdaq uplisting.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-29
Item 3.02
In connection with the financing, Onar issued 9,202,613 shares of Common Stock as incentive shares and Warrants exercisable for 102,251,256 shares, all offered and sold in reliance on Section 4(a)(2) and Rule 506 in a private placement at a $25 million pre-money valuation.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-09-29
Item 7.01
Onar Holding Corp announced completion of financing to fund the largest acquisition in Company history of a leading U.S. affiliate marketing agency, with the $15 million financing and $5 million senior secured facility proceeds intended to fund the cash consideration for the previously announced acquisition.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-09-29
Item 4.01
The filing discloses the dismissal of Gillespie & Associates as the independent registered public accounting firm on September 27, 2026, and the appointment of Privatco CPA Limited as the new auditor on September 22, 2026. This is a classic auditor change under Item 4.01. While the prior auditor's reports contained a going-concern warning, the core event is the change in auditors itself, which is material to investors' assessment of financial reporting reliability and governance.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-29
Item 8.01
The disclosure reports a Brazilian Provisional Measure (signed September 25, 2026) that prohibits online betting and casino operations in Brazil and requires return of funds to bettors. While the Company characterizes Brazil as an "immaterial share" of revenue and states its exposure is "limited," the regulatory action materially affects the Company's ability to operate in a market where it holds a license (through Meridianbet). This is a significant operational and regulatory event that would affect investor assessment of the Company's market access and future revenue prospects, even if quantitatively immaterial to current results.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-09-29
Liberty Star entered into a Securities Purchase Agreement with Monroe Street Capital Partners LP to issue a convertible promissory note with principal amount of $95,700 (including 10% original issue discount). The note is convertible into shares of common stock, making this a dilutive equity issuance. While Item 1.01 frames this as a "material definitive agreement" and Item 2.03 addresses the debt obligation, the core economic substance is an unregistered convertible debt issuance that will dilute existing shareholders upon conversion.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-29
The filing discloses positive interim clinical trial results from the Phase 2 NEXICART-2 trial of NXC-201, showing an 89% complete response rate across 45 relapsed/refractory AL Amyloidosis patients, with potential to reach 98% when accounting for MRD-negative patients. While the disclosure is made under Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events) rather than a dedicated clinical-results Item, the substance is a material operational/clinical milestone for a biopharmaceutical company with a lead product candidate in Phase 2 development. This is not an earnings release (no financial results), but rather a clinical development milestone that would materially affect investor assessment of the company's pipeline progress and regulatory pathway toward BLA submission planned for mid-2027.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-09-29
EX-99.1
This exhibit announces a material operational restructuring and cost-reduction initiative. MMA.INC has implemented over US$2.51 million in annualized cash operating cost reductions (a 47.2% increase since June 30, 2026) through workforce reductions (~US$445,000 in staff costs), premises consolidation (~US$116,000), and technology optimization. While the disclosure emphasizes completed actions and operational discipline rather than a discrete event like a bankruptcy or covenant breach, the scale of the restructuring—involving significant headcount reduction, facility consolidation, and infrastructure changes—materially affects the company's operating model and path to profitability. This is an operational restructuring that does not fit the specific `workforce_reduction` category (which typically pairs with a restructuring charge) but is clearly material to investor assessment of the company's financial trajectory and runway."
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-09-29
EX-99.1
This shareholder letter announces multiple operational milestones: first tungsten concentrate production at Sangdong Mine after 33 years of dormancy, Phase II expansion officially approved with equipment orders placed, a multi-year offtake agreement for Los Santos tailings recovery in Spain, and formation of a joint venture with Rwanda's government for tungsten collection and processing. These are material operational and strategic developments affecting the company's production capacity and market position, but do not fit discrete event categories like M&A, impairment, or earnings release—they are operational/strategic announcements best classified as operational_other.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-09-29
The filing discloses Item 3.01 notification from Nasdaq granting SurgePays an additional 180-calendar-day compliance period (until March 22, 2027) to regain compliance with the minimum $1.00 bid price requirement. The company previously failed to meet this requirement, and failure to cure by the deadline will result in delisting. This is a material delisting risk event that directly threatens the company's continued listing on Nasdaq.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-09-29
EX-99.1
This is a press release announcing PowerBank's fiscal year end results for the twelve-month period ended June 30, 2026. The exhibit discloses key financial metrics including revenues ($27.4M vs. $41.5M prior year), gross profit (34.7% margin vs. 25.3%), net loss ($24.3M vs. $31.1M), and adjusted EBITDA ($3.5M loss vs. $0.8M loss), along with detailed reconciliations and management commentary. The disclosure is material as it reports annual financial performance and would affect a reasonable investor's assessment of the company's financial condition and operational trajectory.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-09-29
The filing discloses an exchange of $1.2 million in debt principal for 120 shares of newly designated Series B Preferred Stock at $10,000 per share, pursuant to an Exchange Agreement dated September 28, 2026. This represents an unregistered issuance of equity securities under Section 4(a)(2) of the Securities Act, with the preferred shares carrying an 8% annual return and redemption rights. The transaction is material as it increases the company's equity base and dilutes existing shareholders while converting debt to equity.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-09-29
The 6-K discloses results of an extraordinary general meeting held on September 29, 2026, where shareholders approved multiple material proposals including a reverse share split at 1-for-150, an increase in authorized share capital, and amendments to the memorandum and articles of association. This is a classic shareholder vote results disclosure that would materially affect investor holdings and capital structure.
View raw filing on EDGAR →
8-K
Governance Other
confidence 92%
filed 2026-09-29
The filing discloses a 1-for-10 reverse stock split approved by stockholders on September 18, 2026 and effective September 29, 2026, filed under Items 3.03 and 5.03 (amendments to articles of incorporation). The reverse split is intended to bring the company into compliance with Nasdaq's minimum bid price requirement for continued listing. While this is a capital structure modification, it is fundamentally a governance/corporate action matter—an amendment to the certificate of incorporation—rather than a specific named event type. The materiality is clear given the delisting compliance purpose and impact on all shareholders' share counts.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-29
This 8-K discloses a shareholder letter from the CEO of Host Digital Inc. following the company's recent merger and public listing (completed earlier in September 2026). The letter provides business updates on the company's data center operations, its first major project ("Site I") with a signed 15-year lease worth approximately $1.25 billion in contracted rent, and the company's growth strategy. While the filing is technically a Regulation FD Disclosure (Item 7.01), the substance is a material operational and strategic update about the company's business model, customer commitments, and capital deployment plans following its transition to public company status. This is material to investors assessing the newly public company's business prospects and execution capability.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-29
The filing discloses the appointment of Bonnie Boyer as Chief Financial Officer effective October 1, 2026, succeeding Norman Roth who transitions to Advisor to the CEO. Item 5.02 explicitly covers this executive appointment, and the prose emphasizes Boyer's qualifications and her role leading the company's next growth phase. While the filing also includes compensation details (base salary $300,000, 30% target bonus, severance provisions), the principal disclosed action is the appointment itself rather than a compensation arrangement.
View raw filing on EDGAR →